Inge Kemper
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 6
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 2
- CAR-T cell therapy research 1
-
- Breast Cancer Treatment Studies 4
- Co-authors
- Gabe S. Sonke (10 shared papers)Ingrid A.M. Mandjes (11 shared papers)Sabine C. Linn (8 shared papers)Erik van Werkhoven (6 shared papers)Mette S. van Ramshorst (5 shared papers)Irma M. Oving (5 shared papers)Aafke H. Honkoop (5 shared papers)Caroline M.P.W. Mandigers (4 shared papers)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)The Breast (2 papers)The Lancet Oncology (1 paper)JAMA Oncology (1 paper)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Inge Kemper
11 papers receiving 455 citations
Peers
Comparison fields: 5 of 34
- Cancer Research 268
- Oncology 381
- Radiology, Nuclear Medicine and Imaging 94
- Pulmonary and Respiratory Medicine 88
- Immunology 52
Countries citing papers authored by Inge Kemper
This map shows the geographic impact of Inge Kemper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Kemper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Kemper more than expected).
Fields of papers citing papers by Inge Kemper
This network shows the impact of papers produced by Inge Kemper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Kemper. The network helps show where Inge Kemper may publish in the future.
Co-authors
The 25 scholars most cited alongside Inge Kemper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 245 | |
| 2 | 2021 | 76 | |
| 3 | 2018 | 34 | |
| 4 | 2016 | 28 | |
| 5 | 2020 | 24 | |
| 6 | 2017 | 21 | |
| 7 | 2023 | 15 | |
| 8 | 2021 | 6 | |
| 9 | 2017 | 5 | |
| 10 | 2020 | 4 | |
| 11 | 2021 | 3 |
About Inge Kemper
Inge Kemper is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 461 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Breast Cancer Treatment Studies (4 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Cells and Metastasis (2 papers), CAR-T cell therapy research (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Cancer Research (268 citations), Oncology (381 citations), Radiology, Nuclear Medicine and Imaging (94 citations), Pulmonary and Respiratory Medicine (88 citations) and Immunology (52 citations). Inge Kemper has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Gabe S. Sonke, Ingrid A.M. Mandjes, Sabine C. Linn, Erik van Werkhoven, Mette S. van Ramshorst, Irma M. Oving, Aafke H. Honkoop, Caroline M.P.W. Mandigers, Lidwine W. Tick and Jelle Wesseling. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Breast, The Lancet Oncology and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.